Transplantation, HomologousHematopoietic Stem Cell TransplantationBone Marrow TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousLiver TransplantationStem Cell TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsKidney TransplantationHematologic NeoplasmsStem CellsTransplantation, IsogeneicGraft vs Tumor EffectPeripheral Blood Stem Cell TransplantationTransplantation ImmunologyTreatment OutcomeHeart TransplantationGraft RejectionRecurrenceHematopoietic Stem CellsHematopoietic Stem Cell MobilizationImmunosuppressive AgentsLung TransplantationHistocompatibility TestingMyeloablative AgonistsHistocompatibilityGraft vs Leukemia EffectRemission InductionVidarabineBlood Component RemovalBusulfanMultiple MyelomaWhole-Body IrradiationCord Blood Stem Cell TransplantationLeukemiaSurvival AnalysisRetrospective StudiesGranulocyte Colony-Stimulating FactorLeukemia, Myeloid, AcuteOrgan TransplantationLymphocyte DepletionAcute DiseaseAntigens, CD34AllograftsSurvival RateImmunosuppressionIslets of Langerhans TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaTime FactorsCyclosporineT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell TransplantationPancreas TransplantationTransplantationMelphalanNuclear FamilyLeukapheresisLymphocyte TransfusionMyelodysplastic SyndromesSalvage TherapyDisease-Free SurvivalHLA AntigensCombined Modality TherapySiblingsLeukemia, MyeloidNeoplasm, ResidualBone Marrow CellsLife TablesSkin TransplantationBlood CellsHepatic Veno-Occlusive DiseaseMice, Inbred C57BLFollow-Up StudiesTransplantation ToleranceTransplantation, HeterotopicImmunomagnetic SeparationAntibodies, NeoplasmAntineoplastic Combined Chemotherapy ProtocolsUnrelated DonorsLiving DonorsCytomegalovirus InfectionsFetal BloodCyclophosphamideBlood DonorsLymphoma, Non-HodgkinMesenchymal Stem Cell TransplantationMice, Inbred BALB CLymphomaPlant StemsIsoantigensHeart-Lung TransplantationAdult Stem CellsPrognosisCell SeparationCytogeneticsAntineoplastic Agents